APOE ε4 has been associated with accumulation of amyloid and/or tau pathology (Nagy et al., 1995; Saito et al., 2002) in AD but the relationship with post-stroke dementia has been conflicting and less well defined. This evidence concerns the gene MAPT and Alzheimer disease.